Yarrow Bioscience, Inc.
YARW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566044
No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q2 2026, worth $8.79M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Yarrow Bioscience, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- 0 vs. Q1 2024
- Shares held
- 7.98M
- +142.9K (+1.8%) vs. Q1 2024
- Total value
- $16.1M
- −$6.80M (−29.7%) vs. Q1 2024
- New holders
- 3
- 12 more added
- Sold out
- 3
- 9 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YARW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $8.79M |
| Q1 2026 | 46 | $8.49M |
| Q4 2025 | 45 | $5.35M |
| Q3 2025 | 36 | $1.33M |
| Q2 2025 | 46 | $13.4M |
| Q1 2025 | 38 | $11.5M |
| Q4 2024 | 35 | $23.4M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 32 | $16.1M |
| Q1 2024 | 32 | $22.9M |
| Q4 2023 | 33 | $18.4M |
| Q3 2023 | 21 | $1.54M |
| Q2 2023 | 20 | $1.63M |
| Q1 2023 | 23 | $1.10M |
| Q4 2022 | 41 | $1.10M |
| Q3 2022 | 41 | $1.84M |
| Q2 2022 | 41 | $3.25M |
| Q1 2022 | 45 | $5.63M |
| Q4 2021 | 55 | $12.5M |
| Q3 2021 | 65 | $20.1M |
| Q2 2021 | 73 | $64.0M |
| Q1 2021 | 87 | $152.4M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Yarrow Bioscience, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Eventide Asset Management, LLC | 1,394,336 | $3.13M | 0.05% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,394,336 | $2.75M | 0.16% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,211,066 | $2.39M | 0.00% | +29,978+2.5% | Added |
| DSC Advisors, L.P. | 696,465 | $1.37M | 4.58% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 467,397 | $920.8K | 0.23% | +381,014+441.1% | Added |
| Palo Alto Investors LP | 445,434 | $877.5K | 0.10% | 00.0% | Unchanged |
| Vanguard Group Inc | 443,518 | $873.7K | 0.00% | +373,885+536.9% | Added |
| Exome Asset Management LLC | 353,434 | $696.3K | 0.62% | −62,000−14.9% | Reduced |
| Parkman Healthcare Partners LLC | 345,206 | $680.1K | 0.09% | −351,264−50.4% | Reduced |
| AlphaCentric Advisors LLC | 310,500 | $611.7K | 0.45% | −134,500−30.2% | Reduced |
| Schonfeld Strategic Advisors LLC | 216,223 | $426.0K | 0.00% | −3,577−1.6% | Reduced |
| ADAR1 Capital Management, LLC | 171,217 | $337.3K | 0.07% | +61,126+55.5% | Added |
| Geode Capital Management, LLC | 135,670 | $267.3K | 0.00% | +28,895+27.1% | Added |
| Prelude Capital Management, LLC | 65,034 | $128.1K | 0.01% | −29,566−31.3% | Reduced |
| Renaissance Technologies LLC | 63,111 | $124.3K | 0.00% | −17,465−21.7% | Reduced |
| BlackRock Inc. | 60,581 | $119.3K | 0.00% | +15,963+35.8% | Added |
| Susquehanna International Group, LLP | 60,323 | $118.8K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 37,655 | $74.2K | 0.00% | +704+1.9% | Added |
| Staley Capital Advisers Inc | 36,472 | $71.8K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 25,058 | $49.4K | 0.00% | +25,042+156,512.5% | Added |
| Lynx1 Capital Management LP | 16,194 | $31.9K | 0.01% | +16,194 | New |
| State Street Corp | 15,765 | $31.1K | 0.00% | +4,100+35.1% | Added |
| Royal Bank of Canada | 4,456 | $9.00K | 0.00% | −170,916−97.5% | Reduced |
| Tower Research Capital LLC (TRC) | 3,383 | $6.67K | 0.00% | +2,142+172.6% | Added |
| Bank of America Corp | 2,306 | $4.54K | 0.00% | +119+5.4% | Added |
| Morgan Stanley | 1,799 | $3.54K | 0.00% | −69−3.7% | Reduced |
| MB, Levis & Associates, LLC | 1,041 | $2.05K | 0.00% | 00.0% | Unchanged |
| Centerpoint Advisors, LLC | 350 | $1.00K | 0.00% | +350 | New |
| Russell Investments Group, Ltd. | 187 | $368 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 176 | $347 | 0.00% | +7+4.1% | Added |
| Wells Fargo & Company | 65 | $128 | 0.00% | −109−62.6% | Reduced |
| Ashton Thomas Private Wealth, LLC | 19 | $37 | 0.00% | +19 | New |
| Virtu Financial LLC | 0 | $0 | 0.00% | −16,199−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,990−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |